Stay updated on VTX958 vs Placebo in Psoriasis Treatment Clinical Trial
Sign up to get notified when there's something new on the VTX958 vs Placebo in Psoriasis Treatment Clinical Trial page.

Latest updates to the VTX958 vs Placebo in Psoriasis Treatment Clinical Trial page
- Check6 days agoChange DetectedThe page header now shows Revision: v3.4.3 and no longer shows Revision: v3.4.2.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedA new page revision tag, v3.4.2, is added. The prior government funding/operating status notice has been removed, and no changes to the study details are observed.SummaryDifference0.3%

- Check41 days agoChange DetectedA funding-status notice was added at the top stating a lapse in government funding and that the NIH Clinical Center is open, and a new Revision: v3.4.1 tag appears replacing the previous v3.4.0 tag. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check48 days agoChange DetectedGlossary visibility has been added. The page also updates labels and capitalization for 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' and shows revision v3.4.0.SummaryDifference0.1%

- Check62 days agoChange DetectedAddition of Revision: v3.3.4 and deletion of Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check84 days agoChange DetectedAdded a detailed Locations section listing study sites by state (AL, AZ, AR, CA, FL, GA, IN, KY, MD, MA, MI, MN, MO, NH, NC, OH, OR, SD, TN, TX, WA) and updated the record to Revision v3.3.3. Removed the HHS Vulnerability Disclosure element.SummaryDifference2%

Stay in the know with updates to VTX958 vs Placebo in Psoriasis Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VTX958 vs Placebo in Psoriasis Treatment Clinical Trial page.